|
NZ702392A
(en)
|
2012-06-08 |
2017-03-31 |
Aduro Biotech |
Compositions and methods for cancer immunotherapy
|
|
EA201590396A1
(ru)
|
2012-12-13 |
2015-12-30 |
Адуро Биотек, Инк. |
Композиция, содержащая циклические пуриновые динуклеотиды с определенной стереохимией, и способ ее получения и применения
|
|
WO2014127378A2
(en)
*
|
2013-02-18 |
2014-08-21 |
Spring Bank Pharmaceuticals, Inc. |
Design of short oligonucleotides as vaccine adjuvants and therapeutic agents
|
|
ME03586B
(me)
|
2013-05-18 |
2020-07-20 |
Univ California |
Sastavi i metode za aktiviranje signaliziranja koje je zavisno od .,stimulatora gena za interferon"
|
|
WO2014189806A1
(en)
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
EP3071209A4
(en)
*
|
2013-11-19 |
2017-08-16 |
The University of Chicago |
Use of sting agonist as cancer treatment
|
|
ES3040431T3
(en)
|
2014-03-12 |
2025-10-31 |
Yeda Res & Dev |
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns
|
|
WO2015185565A1
(en)
|
2014-06-04 |
2015-12-10 |
Glaxosmithkline Intellectual Property Development Limited |
Cyclic di-nucleotides as modulators of sting
|
|
CH710524A2
(fr)
|
2014-12-18 |
2016-06-30 |
Swatch Group Res & Dev Ltd |
Résonateur d'horlogerie à lames croisées.
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
JO3746B1
(ar)
|
2015-03-10 |
2021-01-31 |
Aduro Biotech Inc |
تركيبات وطرق لتنشيط الإشارات المعتمدة على "منبه أو تحفيز جين انترفيرون"
|
|
MX2018001814A
(es)
*
|
2015-08-13 |
2018-05-07 |
Merck Sharp & Dohme |
Compuestos dinucleotidos ciclicos como agonistas del estimulador de genes de interferon.
|
|
UY36969A
(es)
*
|
2015-10-28 |
2017-05-31 |
Novartis Ag |
Composiciones y métodos para activar la señalización dependiente del estimulador del gen de interferon
|
|
JP6411676B2
(ja)
*
|
2015-12-03 |
2018-10-24 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Stingの調節因子としての環状プリンジヌクレオチド
|
|
CN106540260A
(zh)
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
干扰素基因刺激蛋白(sting)激动剂在抗阿尔兹海默症中的应用
|
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
|
HUE073018T2
(hu)
|
2016-01-11 |
2026-01-28 |
Innate Tumor Immunity Inc |
Ciklikus dinukleotidok állapotok kezelésére, amelyek STING-aktivitással kapcsolatosak, mint például rák
|
|
WO2017123657A1
(en)
|
2016-01-11 |
2017-07-20 |
Gary Glick |
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
|
|
WO2017151922A1
(en)
|
2016-03-02 |
2017-09-08 |
The Board Of Regents Of The University Of Texas System |
Sting activating nanovaccine for immunotherapy
|
|
CN114751950B
(zh)
|
2016-03-18 |
2025-04-18 |
免疫传感器公司 |
环二核苷酸化合物及使用方法
|
|
WO2017186711A1
(en)
*
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
|
EP3507367A4
(en)
|
2016-07-05 |
2020-03-25 |
Aduro BioTech, Inc. |
CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
|
|
WO2018045204A1
(en)
|
2016-08-31 |
2018-03-08 |
Ifm Therapeutics, Inc |
Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
|
|
US10414747B2
(en)
|
2016-10-04 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene compounds as sting agonists
|
|
PT3512861T
(pt)
|
2016-12-01 |
2021-04-29 |
Takeda Pharmaceuticals Co |
Dinucleotídeos cíclicos
|
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
|
AU2017378783A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
|
JP7591348B2
(ja)
|
2017-02-21 |
2024-11-28 |
ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム |
インターフェロン遺伝子刺激因子依存性シグナル伝達のアゴニストとしての環状ジヌクレオチド
|
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
|
WO2018208667A1
(en)
|
2017-05-12 |
2018-11-15 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
|
KR20200028392A
(ko)
|
2017-06-12 |
2020-03-16 |
유니버시티 오브 마이애미 |
질환의 치료를 위한 sting-의존성 활성화제
|
|
JP2020524718A
(ja)
|
2017-06-22 |
2020-08-20 |
キュラデブ・ファーマ・リミテッドCuradev Pharma Limited |
ヒトstingの複素環式小分子調節因子
|
|
CA3067257A1
(en)
|
2017-06-22 |
2018-12-27 |
Curadev Pharma Limited |
Small molecule modulators of human sting
|
|
JP2020524717A
(ja)
|
2017-06-22 |
2020-08-20 |
キュラデブ・ファーマ・リミテッドCuradev Pharma Limited |
ヒトstingの小分子調節因子
|
|
JP2020530838A
(ja)
|
2017-08-04 |
2020-10-29 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
がん治療のためのベンゾ[b]チオフェンSTINGアゴニスト
|
|
AU2018311965A1
(en)
|
2017-08-04 |
2020-02-13 |
Merck Sharp & Dohme Llc |
Combinations of PD-1 antagonists and benzo[b]thiophene sting antagonists for cancer treatment
|
|
WO2019035901A1
(en)
|
2017-08-15 |
2019-02-21 |
University Of Miami |
COMPOSITIONS AND METHODS FOR STING PROTEIN MODULATION
|
|
US11638716B2
(en)
|
2017-08-31 |
2023-05-02 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
WO2019067468A1
(en)
|
2017-09-26 |
2019-04-04 |
La Jolla Institute For Allergy And Immunology |
MODULATION OF THE IMMUNE RESPONSE THROUGH THE STING PROTEIN
|
|
SG11202004442VA
(en)
|
2017-11-20 |
2020-06-29 |
Silicon Swat Inc |
Oxoacridinyl acetic acid derivatives and methods of use
|
|
WO2019104353A1
(en)
|
2017-11-27 |
2019-05-31 |
Children's Medical Center Corporation |
Stimulator of interferon genes (sting) ligands and uses thereof
|
|
EP3727401A4
(en)
|
2017-12-20 |
2022-04-06 |
Merck Sharp & Dohme Corp. |
CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
|
|
WO2019147509A1
(en)
|
2018-01-26 |
2019-08-01 |
The Regents Of The University Of California |
Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
|
|
WO2019161171A1
(en)
*
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
|
CA3091670C
(en)
|
2018-02-21 |
2023-02-28 |
The Scripps Research Institute |
6(1h-imidazolyl)pyridazine compounds as agonists of stimulator of interferon genes sting
|
|
WO2019191070A1
(en)
|
2018-03-26 |
2019-10-03 |
University Of Miami |
Recombinant viral vector and uses thereof
|
|
EP3774764A1
(en)
|
2018-04-03 |
2021-02-17 |
Merck Sharp&Dohme Corp. |
Benzothiophenes and related compounds as sting agonists
|
|
US11702430B2
(en)
|
2018-04-03 |
2023-07-18 |
Merck Sharp & Dohme Llc |
Aza-benzothiophene compounds as STING agonists
|
|
US20210228648A1
(en)
|
2018-06-04 |
2021-07-29 |
Aarhus Universitet |
Worm products and methods of use
|
|
US12162863B2
(en)
|
2018-06-12 |
2024-12-10 |
Ryvu Therapeutics S.A. |
Modulators of stimulator of interferon genes (STING)
|
|
CN108498529A
(zh)
|
2018-06-20 |
2018-09-07 |
福建师范大学 |
用于肿瘤预防治疗的DNA甲基转移酶抑制剂与cGAMP药物组合物
|
|
WO2019243823A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Azaheterocyclic small molecule modulators of human sting
|
|
WO2019243825A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Small molecule modulators of human sting, conjugates and therapeutic applications
|
|
MA53095A
(fr)
|
2018-07-03 |
2021-05-12 |
Ifm Due Inc |
Composés et compositions pour traiter des états pathologiques associés à une activité de sting
|
|
WO2020010451A1
(en)
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
|
JP7468829B2
(ja)
|
2018-07-23 |
2024-04-16 |
フォースン オリノーヴ ファーマテック インコーポレイテッド |
癌を処置するための、癌治療剤と組み合わせたIRE1α阻害剤
|